Terms: = Thyroid cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Treatment
902 results:
1. Management of Advanced Medullary thyroid Carcinoma: Current Systemic Therapy Options.
Jara MA
Crit Rev Oncog; 2024; 29(3):83-90. PubMed ID: 38683155
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of tyrosine kinase inhibitors for advanced metastatic thyroid cancer: A systematic review and network meta-analysis of randomized controlled trials.
Zhao M; Li R; Song Z; Miao C; Lu J
Medicine (Baltimore); 2024 Apr; 103(15):e37655. PubMed ID: 38608050
[TBL] [Abstract] [Full Text] [Related]
3. Combining radiomics with thyroid imaging reporting and data system to predict lateral cervical lymph node metastases in medullary thyroid cancer.
Liu Z; Zhang X; Zhao X; Guo Q; Li Z; Wei M; Niu L; An C
BMC Med Imaging; 2024 Mar; 24(1):64. PubMed ID: 38500053
[TBL] [Abstract] [Full Text] [Related]
4. Subgroup analysis of steadily increased trends in medullary thyroid carcinoma incidence and mortality in the USA, 2000-2020: a population-based retrospective cohort study.
Tao Z; Deng X; Guo B; Ding Z; Fan Y
Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38376827
[TBL] [Abstract] [Full Text] [Related]
5. The role of prophylactic parathyroidectomy during thyroidectomy for mtc in patients with MEN2A syndrome.
Kavazis C; Romanidis K; Pitiakoudis M; Kesisoglou I; Laskou S; Sapalidis K
Folia Med (Plovdiv); 2023 Oct; 65(5):720-727. PubMed ID: 38351753
[TBL] [Abstract] [Full Text] [Related]
6. Glucagon-Like Peptide-1 Receptor Agonists and thyroid cancer: A Narrative Review.
Espinosa De Ycaza AE; Brito JP; McCoy RG; Shao H; Singh Ospina N
Thyroid; 2024 Apr; 34(4):403-418. PubMed ID: 38343381
[No Abstract] [Full Text] [Related]
7. Extent of Surgery for Medullary thyroid cancer and Prevalence of Occult Contralateral Foci.
Mao YV; Hughes EG; Steinmetz D; Troob S; Kim J; Tseng CH; Fishbein GA; Sajed DP; Livhits MJ; Yeh MW; Lee D; Angell TE; Wu JX
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):209-214. PubMed ID: 38270925
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients.
Zheng X; Fang M; Fan Y; Sun Y; Sun M; Yang A; Zhang B; Liu Q; Liu H; Zhou X; Huang T; Qin J; Wang Z; Qin M; Shen Z; Yao S; Yang J; Wang Y; Gao M
Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38261313
[TBL] [Abstract] [Full Text] [Related]
9. Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
Aksoy YA; Xu B; Viswanathan K; Ahadi MS; Al Ghuzlan A; Alzumaili B; Bani MA; Barletta JA; Chau N; Chou A; Clarkson A; Clifton-Bligh RJ; De Leo A; Dogan S; Ganly I; Ghossein R; Gild ML; Glover AR; Hadoux J; Lamartina L; Lubin DJ; Magliocca K; Najdawi F; Nigam A; Papachristos A; Repaci A; Robinson BG; Sheen A; Shi Q; Sidhu SB; Sioson L; Solaroli E; Sywak MS; Tallini G; Tsang V; Turchini J; Untch BR; Gill AJ; Fuchs TL
Histopathology; 2024 May; 84(6):947-959. PubMed ID: 38253940
[TBL] [Abstract] [Full Text] [Related]
10. [Precision medicine in endocrinology exemplified by medullary thyroid cancer].
Brandenburg T; Machlah YM; Führer D
Inn Med (Heidelb); 2024 Mar; 65(3):202-210. PubMed ID: 38231404
[TBL] [Abstract] [Full Text] [Related]
11. [Individualization of treatment in sporadic and hereditary medullary thyroid cancer].
Lorenz K; Machens A; Dralle H
Chirurgie (Heidelb); 2024 Mar; 95(3):186-191. PubMed ID: 38214736
[TBL] [Abstract] [Full Text] [Related]
12. Use of Neoadjuvant Vandetanib in Aggressive Pediatric Medullary thyroid Carcinoma.
Kothari R; Kreimer S; Nadel H; Seeley H; Hartman G; Meister KD
JCO Precis Oncol; 2024 Jan; 8():e2300257. PubMed ID: 38207224
[TBL] [Abstract] [Full Text] [Related]
13. Survival Outcomes of Medullary thyroid cancer With and Without Amyloid Deposition.
Toraih E; Hussein M; Anker A; Baah S; Pinion D; Jishu J; Sadakkadulla S; Case M; LaForteza A; Moroz K; Kandil E
Endocr Pract; 2024 Apr; 30(4):311-318. PubMed ID: 38184237
[TBL] [Abstract] [Full Text] [Related]
14. Updated efficacy and safety of entrectinib in Ntrk fusion-positive non-small cell lung cancer.
Cho BC; Chiu CH; Massarelli E; Buchschacher GL; Goto K; Overbeck TR; Loong HHF; Chee CE; Garrido P; Dong X; Fan Y; Lu S; Schwemmers S; Bordogna W; Zeuner H; Osborne S; John T
Lung Cancer; 2024 Feb; 188():107442. PubMed ID: 38171156
[TBL] [Abstract] [Full Text] [Related]
15. A clinical perspective on ectopic Cushing's syndrome.
Ragnarsson O; Juhlin CC; Torpy DJ; Falhammar H
Trends Endocrinol Metab; 2024 Apr; 35(4):347-360. PubMed ID: 38143211
[TBL] [Abstract] [Full Text] [Related]
16. Patterns of treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary thyroid Carcinoma.
Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
[TBL] [Abstract] [Full Text] [Related]
17. Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer.
Maniakas A; Sullivan A; Hu MI; Busaidy NL; Cabanillas ME; Dadu R; Waguespack SG; Fisher SB; Graham PH; Gross ND; Grubbs EG; Perrier ND; Wang JR; Gunn B; Garden AS; Megahed R; Navuluri S; Li X; Williams MD; Zafereo M
Head Neck; 2024 Feb; 46(2):328-335. PubMed ID: 38009416
[TBL] [Abstract] [Full Text] [Related]
18. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered thyroid cancer: Updated Efficacy and Safety Data from the ARROW Study.
Subbiah V; Hu MI; Mansfield AS; Taylor MH; Schuler M; Zhu VW; Hadoux J; Curigliano G; Wirth L; Gainor JF; Alonso G; Adkins D; Godbert Y; Ahn MJ; Cassier PA; Cho BC; Lin CC; Zalutskaya A; Barata T; Trask P; Scalori A; Bordogna W; Heinzmann S; Brose MS
Thyroid; 2024 Jan; 34(1):26-40. PubMed ID: 38009200
[No Abstract] [Full Text] [Related]
19. The Evolving treatment Landscape of Medullary thyroid cancer.
Laganà M; Cremaschi V; Alberti A; Vodopivec Kuri DM; Cosentini D; Berruti A
Curr Treat Options Oncol; 2023 Dec; 24(12):1815-1832. PubMed ID: 37979019
[TBL] [Abstract] [Full Text] [Related]
20. Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.
Ahmed S; Wedekind MF; Del Rivero J; Raygada M; Lockridge R; Glod JW; Flowers C; Thomas BJ; Bernstein DB; Kapustina OB; Jain A; Miettinen M; Raffeld M; Xi L; Tyagi M; Kim J; Aldape K; Malayeri AA; Kaplan RN; Allen T; Vivelo CA; Sandler AB; Widemann BC; Reilly KM;
Cancer Res Commun; 2023 Dec; 3(12):2468-2482. PubMed ID: 37966258
[TBL] [Abstract] [Full Text] [Related]
[Next]
